Clinical significance of hemostatic activation markers in women with suspected ovarian cancer

被引：0
|
作者：
Claussen, C. [1 ]
Rausch, A. V. [2 ]
Spath, B. [1 ]
Lezius, S. [3 ]
Bokemeyer, C. [1 ]
Mahner, S. [2 ]
Langer, F. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, UCCH, Med Klin & Poliklin 2, Hamburg, Germany
[2] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Gynakol, Hamburg, Germany
[3] Univ Klinikum Hamburg Eppendorf, Inst Med Biometrie & Epidemiol, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V669
引用
收藏
页码：214 / 216
页数：2
相关论文
共 50 条
  • [1] Clinical significance of circulating tissue factor (TF) in women with suspected ovarian cancer
    Claussen, C.
    Rausch, A., V
    Spath, B.
    Lezius, S.
    Amirkhosravi, A.
    Davila, M.
    Francis, J. L.
    Bokemeyer, C.
    Jaenicke, F.
    Mahner, S.
    Langer, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 815 - 815
  • [2] Cancer stem cells markers in ovarian cancer: Clinical and therapeutic significance (Review)
    Krolewska-Daszczynska, Patrycja
    Wendlocha, Dominika
    Smycz-Kubanska, Marta
    Stepien, Sebastian
    Mielczarek-Palacz, Aleksandra
    [J]. ONCOLOGY LETTERS, 2022, 24 (06)
  • [3] Investigating women with suspected ovarian cancer
    Spencer, John A.
    Forstner, Rosemarie
    Hricak, Hedvig
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (02) : 262 - 264
  • [4] The prognostic significance of molecular markers in younger women with advanced ovarian cancer.
    Chan, JK
    Loizzi, V
    Magistris, A
    Lin, F
    Rutgers, J
    Osann, K
    DiSaia, PJ
    Berman, ML
    [J]. JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2004, 11 (02) : 401A - 401A
  • [5] Clinical significance of selected angiogenesis and lymphangiogenesis modulators and markers in ovarian cancer patients
    Klasa-Mazurkiewicz, D.
    Milczek, T.
    Jarzab, M.
    Narkiewicz, J.
    Lipinska, B.
    Wydra, D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Tumor Markers and Their Diagnostic Significance in Ovarian Cancer
    Matsas, Alkis
    Stefanoudakis, Dimitrios
    Troupis, Theodore
    Kontzoglou, Konstantinos
    Eleftheriades, Makarios
    Christopoulos, Panagiotis
    Panoskaltsis, Theodoros
    Stamoula, Eleni
    Iliopoulos, Dimitrios C.
    [J]. LIFE-BASEL, 2023, 13 (08):
  • [7] Clinical Significance of Combined Detection of Serum Tumor Markers in Diagnosis of Patients with Ovarian Cancer
    Bian, Jing
    Li, Bo
    Kou, Xian-Juan
    Liu, Tian-Zhou
    Ming, Liang
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6241 - 6243
  • [8] Clinical tumour markers in ovarian cancer
    Mazurek, A
    Niklinski, J
    Laudanski, T
    Pluygers, E
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 1998, 7 (01) : 23 - 35
  • [9] Lymphocyte activation markers in patients with ovarian cancer
    Nowicka, Aldona
    Rogala, Ewelina
    Bednarek, Wieslawa
    Barczynski, Bartlomiej
    Wertel, Iwona
    Piekarczyk, Wanda
    Kotarski, Jan
    [J]. GINEKOLOGIA POLSKA, 2012, 83 (10) : 737 - 743
  • [10] Significance of immunohistochemical markers in women with breast cancer
    Caparlar, M. A.
    Dokcu, S.
    Eroglu, A.
    [J]. NIGERIAN JOURNAL OF CLINICAL PRACTICE, 2023, 26 (03) : 314 - 318
12345